Mozobil (Plerixafor) Injection Package Insert

Chinese package insert for Mozobil (plerixafor) injection 1.2 ml:24 mg, covering indications, dosing, renal-impairment adjustments and adverse reactions.


Mozobil (Plerixafor) Injection Package Insert - cover page
Brand
Mozobil
Category
Drugs
Document type
User Manual
Language
Chinese
Pages
17
File format
PDF
File size
559 KB
Published
16 November, 2026
Updated
16 November, 2026
MD5 checksum
5BADDACAC2F09D247E6FFF3268F22568

About this manual

This is the Chinese prescribing information (package insert) for Mozobil (释倍灵), plerixafor injection, supplied as 1.2 ml of a 20 mg/mL clear, colorless to pale-yellow solution. It is indicated for use with G-CSF to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) so that stem cells can be collected and used for autologous transplantation.

The document gives the recommended subcutaneous dose based on body weight (20 mg fixed dose or 0.24 mg/kg for patients ≤83 kg; 0.24 mg/kg for patients >83 kg, not exceeding 40 mg/day), dosing 11 hours before each collection for up to 4 consecutive days after 4 days of G-CSF, dose reduction in moderate to severe renal impairment, and notes on pediatric and elderly patients. It also lists adverse reactions from clinical trials and post-marketing reports, contraindications, and warnings including anaphylaxis, leukocytosis, thrombocytopenia, splenomegaly and spleen rupture. This manual is written in Chinese.

What's inside

  • Drug Name
  • Ingredients
  • Description
  • Indications
  • Strength
  • Dosage and Administration
  • Dosage in Renal Impairment
  • Pediatric and Elderly Patients
  • Adverse Reactions
  • Contraindications

Specifications

Strength1.2 ml : 24 mg
Concentration20 mg/mL
Molecular formulaC28H54N8
Molecular weight502.79
AppearanceClear, colorless to pale-yellow liquid
Recommended dose, body weight ≤83 kg20 mg fixed dose or 0.24 mg/kg
Maximum daily dose40 mg/day

Frequently asked questions

What is plerixafor injection used for?

In combination with G-CSF, it is used to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma and multiple myeloma, so the cells can be collected and used for autologous transplantation.

What is the recommended dose of Mozobil (plerixafor)?

Patients weighing 83 kg or less receive a 20 mg fixed dose or 0.24 mg/kg; patients over 83 kg receive 0.24 mg/kg, and the dose must not exceed 40 mg per day.

How is the dose adjusted in patients with renal impairment?

In patients with estimated creatinine clearance ≤50 mL/min the dose is reduced by one third (13 mg or 0.16 mg/kg) and must not exceed 27 mg per day.

When is plerixafor given before stem cell collection?

It is given 11 hours before each collection, for up to 4 consecutive days, after the patient has received G-CSF once daily for 4 days.

Download PDF (559 KB)